Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04128878 · ClinicalTrials.gov registry record
Improvement in Endothelial Dysfunction After Initiation of Anti-arrhythmic Therapy in Atrial Fibrillation Patients
A clinical trial, sponsored by Samir Saba.
- Completed
- Registry status
- 12
- Enrollment target
NCT04128878: Completed study, sponsored by Samir Saba.
NCT04128878 is a clinical trial that has completed, run by Samir Saba. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04128878 has completed, sponsored by Samir Saba.
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
Study Summary
This is a prospective, observational study that will examine endothelial dysfunction in atrial fibrillation before and after treatment with anti-arrhythmic agents and the extent to which baseline endothelial dysfunction improves after treatment.
Primary Outcome
Change in microvascular endothelium dependent dilation (in response to acetylcholine) assessed with laser speckle contrast imaging after initiating antiarrhythmic medical therapy.
Interventions
- DRUG Sotalol
- DRUG Dofetilide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2019-05-01 |
| Est. Completion | 2020-12-31 |
What the finished NCT04128878 record still lists
NCT04128878 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 12 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Sotalol is the first listed.
NCT04128878 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04128878 about?
NCT04128878 is a clinical study titled "Improvement in Endothelial Dysfunction After Initiation of Anti-arrhythmic Therapy in Atrial Fibrillation Patients". This is a prospective, observational study that will examine endothelial dysfunction in atrial fibrillation before and after treatment with anti-arrhythmic agents and the extent to which baseline endothelial dysfunction improves after treatment.
What is the current status of trial NCT04128878?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2019-05-01. Estimated completion is 2020-12-31.
What interventions are being tested in trial NCT04128878?
The interventions under investigation include: Sotalol (DRUG), Dofetilide (DRUG).
Who is sponsoring clinical trial NCT04128878?
This trial is sponsored by Samir Saba, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI